chr9-128627469-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001130438.3(SPTAN1):​c.6660C>T​(p.Asn2220Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00131 in 1,551,172 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0061 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00079 ( 7 hom. )

Consequence

SPTAN1
NM_001130438.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.262

Publications

2 publications found
Variant links:
Genes affected
SPTAN1 (HGNC:11273): (spectrin alpha, non-erythrocytic 1) Spectrins are a family of filamentous cytoskeletal proteins that function as essential scaffold proteins that stabilize the plasma membrane and organize intracellular organelles. Spectrins are composed of alpha and beta dimers that associate to form tetramers linked in a head-to-head arrangement. This gene encodes an alpha spectrin that is specifically expressed in nonerythrocytic cells. The encoded protein has been implicated in other cellular functions including DNA repair and cell cycle regulation. Mutations in this gene are the cause of early infantile epileptic encephalopathy-5. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010]
SPTAN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuronopathy, distal hereditary motor, autosomal dominant 11
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spastic paraplegia
    Inheritance: AR Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 9-128627469-C-T is Benign according to our data. Variant chr9-128627469-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 139311.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.262 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00609 (928/152314) while in subpopulation AFR AF = 0.0207 (859/41574). AF 95% confidence interval is 0.0195. There are 7 homozygotes in GnomAd4. There are 456 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 928 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001130438.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTAN1
NM_001130438.3
MANE Select
c.6660C>Tp.Asn2220Asn
synonymous
Exon 50 of 57NP_001123910.1Q13813-2
SPTAN1
NM_001375318.1
c.6696C>Tp.Asn2232Asn
synonymous
Exon 51 of 59NP_001362247.1
SPTAN1
NM_001375310.1
c.6747C>Tp.Asn2249Asn
synonymous
Exon 51 of 58NP_001362239.1A0A994J6W3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTAN1
ENST00000372739.7
TSL:1 MANE Select
c.6660C>Tp.Asn2220Asn
synonymous
Exon 50 of 57ENSP00000361824.4Q13813-2
SPTAN1
ENST00000372731.8
TSL:1
c.6645C>Tp.Asn2215Asn
synonymous
Exon 49 of 56ENSP00000361816.4Q13813-1
SPTAN1
ENST00000358161.9
TSL:1
c.6585C>Tp.Asn2195Asn
synonymous
Exon 48 of 55ENSP00000350882.6Q13813-3

Frequencies

GnomAD3 genomes
AF:
0.00606
AC:
922
AN:
152196
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0206
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00136
AC:
215
AN:
157846
AF XY:
0.000972
show subpopulations
Gnomad AFR exome
AF:
0.0188
Gnomad AMR exome
AF:
0.00125
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000363
Gnomad OTH exome
AF:
0.000224
GnomAD4 exome
AF:
0.000786
AC:
1100
AN:
1398858
Hom.:
7
Cov.:
31
AF XY:
0.000722
AC XY:
498
AN XY:
689980
show subpopulations
African (AFR)
AF:
0.0214
AC:
675
AN:
31594
American (AMR)
AF:
0.00151
AC:
54
AN:
35718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25186
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35738
South Asian (SAS)
AF:
0.000101
AC:
8
AN:
79260
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48598
Middle Eastern (MID)
AF:
0.00369
AC:
21
AN:
5698
European-Non Finnish (NFE)
AF:
0.000229
AC:
247
AN:
1079048
Other (OTH)
AF:
0.00164
AC:
95
AN:
58018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
58
116
175
233
291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00609
AC:
928
AN:
152314
Hom.:
7
Cov.:
32
AF XY:
0.00612
AC XY:
456
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0207
AC:
859
AN:
41574
American (AMR)
AF:
0.00203
AC:
31
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000397
AC:
27
AN:
68026
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
50
99
149
198
248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00281
Hom.:
2
Bravo
AF:
0.00665
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
Developmental and epileptic encephalopathy, 5 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)
-
-
1
SPTAN1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
8.8
DANN
Benign
0.70
PhyloP100
-0.26
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112955915; hg19: chr9-131389748; COSMIC: COSV63990040; COSMIC: COSV63990040; API